U.S. General Merchandise and Department Stores Stock News

Index reshuffles have put Acadia Healthcare Company (ACHC) in focus, as the stock moves out of several Russell 1000 and midcap benchmarks and into the Russell 2000 and its value subset. See our latest analysis for Acadia Healthcare Company. The index reshuffle comes during a sharp shift in momentum for Acadia Healthcare Company, with the share price delivering a 21.41% 1 month return and 115.12% year to date, but a 59.01% decline in 3 year total shareholder return. This highlights how recent...

Enerpac Tool Group (EPAC) has just posted its Q3 2026 numbers, with revenue of US$167.6 million and net income of US$29.8 million translating to basic EPS of US$0.58, against a trailing twelve month EPS base of US$1.78 and net income of US$93.3 million on revenue of US$634.1 million. The company has seen quarterly revenue move around the mid US$140 million to US$160 million range over recent periods, with basic EPS between roughly US$0.31 and US$0.58 per quarter. Earnings over the last year...

In late June and early July 2026, Digi International announced the global availability of its ConnectCore 95 SMARC development kit and unveiled DANI, an embedded AI network-operations agent within Digi Remote Manager, while also shifting across multiple Russell growth indexes. Together, these moves highlight Digi’s effort to bundle hardware, security, lifecycle cloud services, and embedded AI into a single, standardized platform aimed at simplifying and scaling connected device deployments...

Penguin Solutions (PENG) opened its Q3 2026 update with total revenue of US$478.7 million and basic EPS of US$0.73, alongside trailing twelve month EPS of US$1.45 on revenue of about US$1.5 billion. This highlights the scale of its current earnings profile. The company has reported quarterly revenue rising from US$324.3 million in Q3 2025 to US$478.7 million in Q3 2026, while basic EPS has shifted from a small loss in Q3 2025 to US$0.73 this quarter. As a result, this reporting season is...

Phibro Animal Health stock has delivered a strong 143.3% return over the past 3 years, yet its current checks still suggest the shares look inexpensive relative to the fundamentals. Phibro Animal Health's 143.3% return over 3 years points to a stock that has already rewarded patient holders, which raises the bar for what counts as good value today. Future growth in animal health demand can support earnings and cash flow, while any pressure on input costs or pricing power may limit how much...

Moderna (NasdaqGS:MRNA) has settled a long running patent dispute with Arbutus Biopharma and Genevant Sciences related to COVID-19 vaccine technology. The agreement includes a US$950 million upfront payment from Moderna to Arbutus and Genevant. The settlement covers lipid nanoparticle technology used in Moderna's COVID-19 vaccine and concludes multi year litigation. Moderna is a large mRNA therapeutics company best known for its COVID-19 vaccine, which relies on lipid nanoparticle delivery...

United States Antimony stock has logged a very large return over three years, yet the valuation checks point to a more muted picture where the Discounted Cash Flow (DCF) intrinsic value sits close to the current share price while market based multiples suggest the stock is expensive. Over the past three years, United States Antimony has returned about 18x, which puts extra attention on whether recent gains are already pricing in much of the good news. Commissioning of new smelting and...

Equifax (NYSE:EFX) has signed a definitive agreement to acquire Círculo de Crédito, a major credit bureau in Mexico. The deal is aimed at expanding Equifax's presence in Mexico's growing credit market. The acquisition is expected to add new data assets and create synergies across Equifax's Latin American operations. For Equifax, the Círculo de Crédito deal fits into its broader role as a global data, analytics, and technology company that supports lenders and other institutions. Mexico's...

Astrana Health stock has delivered a strong 86.5% return over the past year, yet its valuation checks lean expensive rather than cheap, giving investors a mixed starting point when assessing the current price near US$46.28. An 86.5% one year return highlights how quickly sentiment has shifted, which raises the bar for what the business needs to deliver to justify the move. Recent optimism around value based care and expectations for stronger earnings can support the current share price, but...

In late June 2026, Sotera Health Company (NasdaqGS: SHC) was removed from several major Russell growth indices, including the Russell 1000 Growth, 2500 Growth, 3000 Growth, 3000E Growth, Midcap Growth, and Small Cap Comp Growth benchmarks. This broad index removal may affect how both passive and active investors view and hold Sotera Health, potentially altering trading patterns and liquidity around the stock. We’ll now examine how Sotera Health’s removal from multiple Russell growth indices...

In late June 2026, Seadrill Limited (NYSE: SDRL) was removed from multiple Russell indices, including the Russell 2000 Growth, Russell 2500 Growth, and Russell 3000 Growth benchmarks, following the annual reconstitution process. This broad index removal can prompt mechanical selling by passive funds and reshuffle the shareholder base, potentially altering trading liquidity and how the stock is benchmarked by institutional investors. We’ll now examine how Seadrill’s removal from several...

In late June 2026, Resideo Technologies, Inc. (NYSE: REZI) was added to multiple Russell growth indexes, including the Russell 3000 Growth, 3000E Growth, 2500 Growth, 2000 Growth, and Small Cap Comp Growth benchmarks. This cluster of index inclusions broadens Resideo’s exposure to passive funds and benchmarked portfolios, potentially deepening liquidity and institutional interest in the stock. With Resideo now included across several Russell growth benchmarks, we’ll examine how this expanded...

Potential U.S. tariffs on Canadian goods and tighter rules on forced labour are putting a spotlight on where companies source and build their products. For investors, that creates both risk and opportunity, as supply chains tied to Canada could face higher costs while more U.S. domestic manufacturing becomes relatively more attractive. This article looks at how that backdrop connects to three stocks from a U.S. Domestic Manufacturing Stocks screener that appear exposed to this news. You will...

On July 1, 2026, S&P Global completed the spin-off of its Mobility division as Mobility Global Inc., which began trading independently on the NYSE under the ticker MBGL, backed by new bylaws, a refreshed board, and leadership appointments across key business units. The spin-off immediately positioned Mobility Global inside a wide range of major equity indices and was accompanied by a more than US$1.01 billion shelf registration tied to an employee stock ownership plan, underscoring its scale...

With the Federal Reserve under Kevin Warsh turning more hawkish and inflation still running at 4.1% on the PCE measure in May, higher for longer interest rates are reshaping where risk and opportunity sit in US large caps. Value stocks with solid balance sheets and dependable dividends are back in focus as investors reassess what they hold through tighter monetary conditions and rising volatility. This article looks at 3 large cap value stocks from our screener that are closely exposed to...

On 27 June 2026, PHINIA Inc. (NYSE: PHIN) was added to multiple Russell growth and small-cap benchmarks, including the Russell 2000 Growth and Russell 3000 Growth indices, broadening its presence across key US equity indices. This broad-based index inclusion is likely to raise PHINIA’s visibility with institutional investors and index-tracking funds that align portfolios with Russell benchmarks. We’ll now explore how PHINIA’s broad Russell growth index inclusion could influence its...

In late June 2026, Sana Biotechnology, Inc. was removed from several major Russell value benchmarks, including the Russell 3000 Value and Russell 2000 Value indexes. This broad removal from key value indexes can materially affect how index funds, quantitative screens, and institutional investors view and hold the stock. We’ll now examine how Sana Biotechnology’s removal from multiple Russell value benchmarks shapes the company’s investment narrative and risk profile. We've uncovered the 9...

EHang Holdings (EH) is drawing attention after being selected for Hong Kong's Low-Altitude Economy Regulatory Sandbox X, which allows compliant trial operations of its pilotless EH216-S eVTOL within the city. See our latest analysis for EHang Holdings. Despite the Hong Kong sandbox announcement highlighting EHang Holdings’ role in urban air mobility, the stock’s recent performance has been weak. The share price is down 30.1% over 30 days, and the 1-year total shareholder return has declined...

Immigration policy rarely shows up on a stock screener, yet the Supreme Court’s TPS decision and a surge in ICE activity could reshape spending patterns for communities and the large retail chains that serve them. With up to 1.3 million workers and consumers facing the loss of legal work status, some retailers may see pressure on store traffic and local revenue, while others might prove more resilient thanks to broad national footprints and diverse customer bases. This article looks at three...

Asbury Automotive Group, Inc. was recently removed from the Russell 2000 Dynamic Index, and previously announced it would release second-quarter 2026 financial results before the market opened on Tuesday, July 28, 2026, with a conference call later that morning. This index removal can influence institutional ownership patterns and trading volumes, potentially affecting how investors view Asbury’s size, liquidity, and role in auto retail portfolios. We’ll now examine how Asbury’s removal...

Global capital is flowing toward US factories, energy systems, and data infrastructure, as foreign investment in the US reaches US$232b in 2025 and reshoring gathers pace. For investors, that mix of policy support, new capacity, and higher planning risk can create both opportunity and potential pitfalls across manufacturing, infrastructure, and technology focused supply chains. This article looks at how those forces intersect with our US Manufacturing and Industrial Reshoring screener and...

Core Natural Resources (CNR) is back on investors’ radar after subsidiary CONSOL Innovations was selected for a multi million dollar U.S. Department of Energy grant tied to rare earth recovery from coal waste. See our latest analysis for Core Natural Resources. Even with the rare earths grant putting Core Natural Resources back in the spotlight, the share price has eased in recent weeks, with a 30 day share price return down 15.28% and a 90 day share price return down 16.33%. At the same...

Social Security’s trust fund is projected to run dry by 2032, and that kind of deadline can reshuffle risk across the U.S. financial sector. Higher government borrowing, pressure on Treasury markets, and shifting interest rates can all influence how banks, insurers, and lenders are priced and perceived. This article looks at what that backdrop could mean for investors and highlights 3 stocks from our U.S. Financial Sector Stocks screener that currently screen well on health, value, and growth...

Merger agreement sets new reference point for Synaptics stock Synaptics (SYNA) is in focus after ON Semiconductor agreed to acquire the company in a stock deal valued at US$6.7b. Synaptics shareholders are set to receive 1.35 ON shares for each SYNA share. See our latest analysis for Synaptics. The ON Semiconductor offer has come after a strong run in Synaptics, with the stock’s 90 day share price return of 57.19% and 1 year total shareholder return of 74.31% contrasting with weaker 5 year...